Detalhe da pesquisa
1.
Minimal acute toxicity from proton beam therapy for major salivary gland cancer.
Acta Oncol
; 59(2): 196-200, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31805791
2.
A topical BRAF inhibitor (LUT-014) for treatment of radiodermatitis among women with breast cancer.
JAAD Int
; 15: 62-68, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38405632
3.
Low contralateral failure rate with unilateral proton beam radiotherapy for oropharyngeal squamous cell carcinoma: A multi-institutional prospective study from the proton collaborative group.
Radiother Oncol
; 190: 109977, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37922991
4.
Proton Therapy Outcomes for Head and Neck Cutaneous Melanoma: Proton Collaborative Group Analysis.
Int J Part Ther
; 9(2): 40-48, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36060417
5.
Work Outcomes after Intensity-Modulated Proton Therapy (IMPT) versus Intensity-Modulated Photon Therapy (IMRT) for Oropharyngeal Cancer.
Int J Part Ther
; 8(1): 319-327, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34285958
6.
Subungual squamous cell carcinoma: radiation therapy as an alternative to amputation and review of the literature.
Am J Clin Dermatol
; 11(4): 285-8, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20108994
7.
A Multi-Institutional Experience of Proton Beam Therapy for Sinonasal Tumors.
Adv Radiat Oncol
; 4(4): 689-698, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31673662
8.
Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies.
Pract Radiat Oncol
; 9(4): 280-288, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30802618
9.
Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer.
J Clin Oncol
; 37(34): 3256-3265, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31618127
10.
Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma.
Thyroid
; 27(7): 944-952, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28446057
11.
Dusquetide: Reduction in oral mucositis associated with enduring ancillary benefits in tumor resolution and decreased mortality in head and neck cancer patients.
Biotechnol Rep (Amst)
; 15: 24-26, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28649557
12.
Dusquetide: A novel innate defense regulator demonstrating a significant and consistent reduction in the duration of oral mucositis in preclinical data and a randomized, placebo-controlled phase 2a clinical study.
J Biotechnol
; 239: 115-125, 2016 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27746305
13.
Comparison of stereotactic body radiation therapy for biopsy-proven versus radiographically diagnosed early-stage non-small lung cancer: a single-institution experience.
Tumori
; 101(3): 287-93, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25908031
14.
Is primary radiotherapy an acceptable treatment modality for verrucous carcinoma of the larynx?
Laryngoscope
; 129(9): 1964-1965, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30950508
15.
Helical image-guided stereotactic body radiotherapy (SBRT) for the treatment of early-stage lung cancer: a single-institution experience at the Willis-Knighton Cancer Center.
Tumori
; 100(1): 42-8, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24675490
16.
Influence of patient characteristics on survival following treatment with helical stereotactic body radiotherapy (SBRT) in stage I non-small-cell lung cancer.
Thorac Cancer
; 4(1): 27-34, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28920325